MedPath

Ayurvedic treatment for mild and moderate depressio

Phase 2
Completed
Conditions
Health Condition 1: F01-F99- Mental, Behavioral and Neurodevelopmental disorders
Registration Number
CTRI/2019/08/020868
Lead Sponsor
SDM Pharmacy Udupi
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
160
Inclusion Criteria

Patients who are diagnosed as suffering from mild and moderate depression

Exclusion Criteria

1.Patients suffering from severe depression

2.Patients having suicidal ideation.

3.Patients associated with major organic pathologies.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Hamilton depression rating scale will be assessed in every 1 month during the treatment and after one month of completion of treatment.Timepoint: 8 weeks
Secondary Outcome Measures
NameTimeMethod
Assessement beck depression inventoryTimepoint: 8 weeks
© Copyright 2025. All Rights Reserved by MedPath